Admission Glucose Does Not Improve GRACE Score at 6 Months and 5 Years after Myocardial Infarction

Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial

(2011) M. de Mulder et al.   DIABETIC MEDICINE

Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome

(2011) Maarten de Mulder et al.   HEART

Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy

(2010) Maarten de Mulder et al.   AMERICAN HEART JOURNAL

Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers

(2010) Kai M. Eggers et al.   AMERICAN HEART JOURNAL

Usefulness of Biomarker Strategy to Improve GRACE Score's Prediction Performance in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome and Low Event Rates

(2010) Farzin Beygui et al.   AMERICAN JOURNAL OF CARDIOLOGY

Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non–ST-Segment Elevation Acute Coronary Syndromes

(2009) Peter R. Sinnaeve   ARCHIVES OF INTERNAL MEDICINE

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Does acute hyperglycemia add prognostic value to the GRACE score in individuals with non-ST elevation acute coronary syndromes?

(2009) Luis C.L. Correia et al.   CLINICA CHIMICA ACTA

N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome

(2009) Sohail Q. Khan et al.   CLINICAL SCIENCE

Hyperglycemia and Acute Coronary Syndrome

(2008) Prakash Deedwania et al.   CIRCULATION